(06-04-13) Study shows insulin injections more than double risk of death in Type II diabetics

by Ethan A. Huff, staff writer

(NaturalNews) According to the World Diabetes Foundation, nearly one-third of
all Type II diabetics take daily insulin injections as part of their prescribed
treatment protocol. But a new study published in The Journal of Clinical
Endocrinology & Metabolism reveals that this quintessential diabetes therapy
option may be responsible for more than doubling the risk of death from all
causes among those with Type II diabetes.

Compiled by researchers from the U.K., the new study involved carefully
scrutinizing the safety of insulin injections in order to gain a more thorough
understanding of the treatment's many possible side effects. Utilizing data
from the U.K. General Practice Research Database, which included nearly 85,000
patients with Type II diabetes, researchers compared the side effects of
insulin injections alone with four other common treatment protocols for the
disease.

Using metformin monotherapy as the baseline referent, the research team
discovered that the risk of having a major cardiac event, developing a first
cancer, or dying jumped by more than 30 percent when insulin was simply added
to metformin treatment for Type II diabetes. Sulfonylurea monotherapy was found
to be associated with a roughly 44 percent increased risk of these same
conditions, while insulin monotherapy alone was associated with an overall 80
percent increased risk.

Compared to metformin monotherapy, sulfonylurea monotherapy, metformin plus
sulfonylurea combination therapy, and insulin plus metformin combination
therapy, insulin monotherapy was found to increase the risk of both stroke and
cancer by about 43 percent, and major adverse cardiac events by about 74
percent. And while risk of myocardial infarction almost doubles while on
insulin monotherapy, risk of neuropathy more than doubles, according to the
figures.

The biggest jump was found with renal complications; however, which are three-
and-a-half times more likely to occur as a result of insulin monotherapy. And
risk of all-cause mortality more than doubles as a result of insulin
monotherapy, illustrating the severe risk factors associated with taking this
commonly-prescribed diabetes medication.

"In people with T2DM (Type II diabetes mellitus), exogenous insulin therapy
was associated with an increased risk of diabetes-related complications,
cancer, and all-cause mortality," wrote the authors in their conclusion. "There
is a clear need to review the way in which exogenous insulin is used in people
with Type II diabetes and to establish in detail the risk-benefit profile at
differing stages of the natural history of the disease and in phenotypically
different subgroups.

You can view the study abstract for yourself here:
http://jcem.endojournals.org/content/98/2/668

You can also learn more about how to cure diabetes naturally, without drugs,
by visiting:
http://www.naturalnews.com/030150_diabetes_Americans.html

Sources for this article include:

http://jcem.endojournals.org/content/98/2/668

http://www.healio.com

http://www.cpmedical.net

News

---

In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.